Healthcare >> CEO Interviews >> April 6, 1998

Donald R. Sellers – Sciclone Pharmaceuticals Inc (scln)

DONALD R. SELLERS has served as President, Chief Executive Officer and Director of SciClone Pharmaceuticals, Inc. since 1996. From 1993 to present, he has also served as Managing Director of SciClone Pharmaceuticals International Ltd. At SciClone, Mr. Sellers has helped bring ZADAXIN', the company's leading immune system-enhancing drug, into Phase III clinical trials in the US and Japan and into 27 countries where it is sold worldwide, generating revenues of $14 million in 2001. Mr. Sellers has nearly 30 years of experience in the global pharmaceutical industry, working with SciClone, Pfizer, Revlon Healthcare Group and Sterling Drug International. Mr. Sellers spent five years in military intelligence, serving with Special Forces and as a Counter-Intelligence Special Agent. He has an AB degree from Lafayette College and a Master of International Management degree with honors from the American Graduate School of International Management. Mr. Sellers speaks five languages. Profile
TWST: Give us a thumbnail sketch, a bit of a summary on SciClone

Pharmaceuticals.

Mr. Sellers: SciClone is a six year old biopharmaceutical company that

acquires, and commercializes